Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 24/5/2020
SIETES contiene 93008 citas

 1 a 20 de 241 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Strang L, Taylor J. Heroin-assisted treatment and supervised drug consumption sites: experience from four countries. Rand Corporation, Santa Monica, California 2018:5 de diciembre. [Ref.ID 102861]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White M, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of inhaled corticosteroids and long-acting ß-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma. A systematic review and meta-analysis. JAMA 2018;319:10 de abril. [Ref.ID 102671]
4.Enlace a cita original Cita con resumen
Wilkinson P, Izmeth Z. Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev 2016:9 de septiembre. [Ref.ID 100956]
5. Cita con resumen
Finch A, Kubler P. The management of gout. Australian Prescriber 2016;39:1 de agosto. [Ref.ID 100572]
6. Cita con resumen
Moncrieff J. Antipsychotic maintenance treatment: time to rethink?. PLOS Medicine 2015;12:4 de agosto. [Ref.ID 99453]
7.Tiene citas relacionadas Cita con resumen
Vaclavkova A, Chimenti S, Arenberger P, Holló P, Sator P-G, Burcklen M, Stefani M, D'Ambrosio D. Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet 2014;384:2036-45. [Ref.ID 98424]
8.Tiene citas relacionadas
Ryan C, Menter A. Ponesimod - a future oral therapy for psoriasis?. Lancet 2014;384:2006-8. [Ref.ID 98423]
9.Tiene citas relacionadas Cita con resumen
McEvoy JP, Byerly M, Hamer RM, Dominik R, Swartz MS, Rosenheck RA, Ray N, Lamberti JS, Buckley PF, Wilkins TM, Stroup TS. Effectiveness of paliperidone vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA 2014;311:1978-87. [Ref.ID 97624]
11. Cita con resumen
Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. JAMA 2014;311:193-4. [Ref.ID 97041]
12. Cita con resumen
Ebbert JO, Hatsukami DK, Croghan IT, Schoreder DR, Allen SS, Hays JT, Hurt RD. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA 2014;311:155-63. [Ref.ID 97037]
13. Cita con resumen
Evins E, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial . JAMA 2014;311:145-54. [Ref.ID 97036]
14.Tiene citas relacionadas Cita con resumen
Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, David AS, O'Connell N, Forrest A, Burns T. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ 2013;347:11. [Ref.ID 96428]
15.Tiene citas relacionadas
Kendall T. Paying people with psychosis to improve adherence. BMJ 2013;347:9. [Ref.ID 96426]
16.Tiene citas relacionadas
Elborn JS, Tunney MM. Macrolides and bronchiectasis: clinical benefit with a resistance price. JAMA 2013;309:1295-6. [Ref.ID 95144]
17.Tiene citas relacionadas Cita con resumen
Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, Biga S, Schlebusch S, Dash P, Bowler SD. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA 2013;309:1260-7. [Ref.ID 95140]
18.Tiene citas relacionadas Cita con resumen
Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren HJ, Koppers RJH, van der Werf TS, Boersma WG. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 2013;309:1251-9. [Ref.ID 95139]
19.Tiene citas relacionadas Cita con resumen
Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, Miranda P, Park MC, Pavelka K, Pedersen R, Szumski A, Hammond C, Koenig AS, Vlahos B. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Lancet 2013;381:918-29. [Ref.ID 95104]
20.Tiene citas relacionadas
Miossec P. Rheumatoid arthritis: still a chronic disease. Lancet 2013;381:884-6. [Ref.ID 95102]
Seleccionar todas
 1 a 20 de 241 siguiente >>